{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T07:02:24Z","timestamp":1762326144243,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030831","name":"Novartis Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030831","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008883","name":"Nagoya City University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jacig.2025.100567","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:18:00Z","timestamp":1757348280000},"page":"100567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of indacaterol\/glycopyrronium\/mometasone for refractory asthmatic cough after switching from inhaled corticosteroid\/long-acting \u03b22-agonist therapy"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4947-4760","authenticated-orcid":false,"given":"Akio","family":"Niimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ohbayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Asamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arihiro","family":"Kiyosue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Miyao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Tochigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinaga","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junpei","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Kanemitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Tajiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johsuke","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2025.100567_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113901","article-title":"Exploring the role of nerves in asthma; insights from the study of cough","volume":"179","author":"Satia","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jacig.2025.100567_bib3","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1080\/02770903.2018.1514628","article-title":"Asthma control and quality of life in a real-life setting: a cross-sectional study of adult asthma patients in Japan (ACQUIRE-2)","volume":"56","author":"Adachi","year":"2019","journal-title":"J Asthma"},{"key":"10.1016\/j.jacig.2025.100567_bib4","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.jaip.2019.02.021","article-title":"Role and impact of chronic cough in individuals with asthma from the general population","volume":"7","author":"\u00c7olak","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2025.100567_bib5","doi-asserted-by":"crossref","first-page":"906","DOI":"10.4168\/aair.2020.12.6.906","article-title":"Understanding the impact of chronic cough on the quality of life in the general population","volume":"12","author":"Jin","year":"2020","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jacig.2025.100567_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1465-9921-15-79","article-title":"Frequent cough in unsatisfactory controlled asthma\u2014results from the population-based West Sweden Asthma study","volume":"15","author":"Mincheva","year":"2014","journal-title":"Respir Res"},{"key":"10.1016\/j.jacig.2025.100567_bib7","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01366-2017","article-title":"Asthma phenotypes: do cough and wheeze predict exacerbations in persistent asthma?","volume":"50","author":"Morjaria","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacig.2025.100567_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1752-699X.2012.00313.x","article-title":"Determinants of asthma control and quality of life in stable asthma: evaluation of two new cough provocation tests","volume":"7","author":"Purokivi","year":"2013","journal-title":"Clin Respir J"},{"key":"10.1016\/j.jacig.2025.100567_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.chest.2019.12.021","article-title":"Managing chronic cough due to asthma and NAEB in adults and adolescents: Chest guideline and expert panel report","volume":"158","author":"C\u00f4t\u00e9","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.jacig.2025.100567_bib10","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1159\/000529251","article-title":"Prevalence of uncontrolled asthma despite treatment with medium- or high-dose ICS\/LABA using patient-reported outcomes in Japan: the KOCU (KnOwing the Controlled statUs of Asthma in Japan) study","volume":"184","author":"Ohbayashi","year":"2023","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jacig.2025.100567_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.alit.2023.02.006","article-title":"Executive summary: Japanese guidelines for adult asthma (JGL), 2021","volume":"72","author":"Niimi","year":"2023","journal-title":"Allergol Int"},{"year":"2021","series-title":"Tokyo (Japan): Asthma Guideline Expert Committee; Japanese Society of Allergology","key":"10.1016\/j.jacig.2025.100567_bib12"},{"key":"10.1016\/j.jacig.2025.100567_bib13","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.jaip.2018.01.016","article-title":"Tiotropium attenuates refractory cough and capsaicin cough reflex sensitivity in patients with asthma","volume":"6","author":"Fukumitsu","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2025.100567_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.anai.2023.03.032","article-title":"Tiotropium for refractory cough in asthma via cough reflex sensitivity: a randomized, parallel, open-label trial","volume":"131","author":"Fukumitsu","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jacig.2025.100567_bib15","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1055\/s-0043-112491","article-title":"Safety and efficacy of glycopyrrolate as a premedication for endoscopic submucosal dissection: a randomized, double-blind, placebo-controlled study","volume":"49","author":"Kim","year":"2017","journal-title":"Endoscopy"},{"key":"10.1016\/j.jacig.2025.100567_bib16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s40265-021-01518-w","article-title":"Indacaterol\/glycopyrronium\/mometasone: a review in asthma","volume":"81","author":"Blair","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.jacig.2025.100567_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2147\/JAA.S392975","article-title":"Mometasone\/indacaterol\/glycopyrronium (MF\/IND\/GLY) and MF\/IND at different MF strengths versus fluticasone propionate\/salmeterol xinafoate (FLU\/SAL) and FLU\/SAL + tiotropium in patients with asthma","volume":"16","author":"van Zyl-Smit","year":"2023","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jacig.2025.100567_bib18","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S2213-2600(20)30190-9","article-title":"Once-daily, single-inhaler mometasone\u2013indacaterol\u2013glycopyrronium versus mometasone\u2013indacaterol or twice-daily fluticasone\u2013salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study","volume":"8","author":"Kerstjens","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jacig.2025.100567_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106021","article-title":"Fixed-dose combination of indacaterol\/glycopyrronium\/mometasone furoate once-daily versus salmeterol\/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: a randomised, phase IIIb, non-inferiority study (ARGON)","volume":"170","author":"Gessner","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.jacig.2025.100567_bib20","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00452-2022","article-title":"Real-life effectiveness of indacaterol\/glycopyrronium\/mometasone for symptomatic relief of cough after switching from inhaled corticosteroid\/long-acting \u03b22-agonist therapy in patients with asthma: REACH study design","volume":"9","author":"Niimi","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jacig.2025.100567_bib21","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S2213-2600(19)30471-0","article-title":"Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial","volume":"8","author":"Smith","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jacig.2025.100567_bib22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.alit.2016.02.014","article-title":"Gastroesophageal dysmotility is associated with the impairment of cough-specific quality of life in patients with cough variant asthma","volume":"65","author":"Kanemitsu","year":"2016","journal-title":"Allergol Int"},{"key":"10.1016\/j.jacig.2025.100567_bib23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/thorax.58.4.339","article-title":"Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)","volume":"58","author":"Birring","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.jacig.2025.100567_bib24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-3-540-79842-2_16","article-title":"Clinical cough IV: what is the minimal important difference for the Leicester Cough Questionnaire?","volume":"187","author":"Raj","year":"2009","journal-title":"Handb Exp Pharmacol"},{"issue":"suppl 64","key":"10.1016\/j.jacig.2025.100567_bib25","first-page":"4563","article-title":"Can we predict response of refractory asthmatic cough to tiotropium? A prospective study","volume":"56","author":"Fukumitsu","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacig.2025.100567_bib32","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.resinv.2014.03.003","article-title":"Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values","volume":"52","author":"Kubota","year":"2014","journal-title":"Respir Investig"},{"key":"10.1016\/j.jacig.2025.100567_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00408-024-00698-y","article-title":"Cough response to high-dose inhaled corticosteroids in patients with chronic cough and fractional exhaled nitric oxide levels \u2265 25 ppb: a prospective study","volume":"202","author":"Lee","year":"2024","journal-title":"Lung"},{"key":"10.1016\/j.jacig.2025.100567_bib27","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3390\/ijerph15061189","article-title":"A muscarinic antagonist reduces airway inflammation and bronchoconstriction induced by ambient particulate matter in a mouse model of asthma","volume":"15","author":"Kurai","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jacig.2025.100567_bib28","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.3390\/ijms19124090","article-title":"How glucocorticoids affect the neutrophil life","volume":"19","author":"Ronchetti","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacig.2025.100567_bib29","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.12998\/wjcc.v10.i21.7187","article-title":"Effects of glucocorticoids on leukocytes: genomic and non-genomic mechanisms","volume":"10","author":"Jia","year":"2022","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.jacig.2025.100567_bib30","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jaip.2018.01.025","article-title":"Inhaled corticosteroids safety and adverse effects in patients with asthma","volume":"6","author":"Heffler","year":"2018","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829325001687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829325001687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:12:30Z","timestamp":1762323150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829325001687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2772829325001687"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2025.100567","relation":{},"ISSN":["2772-8293"],"issn-type":[{"type":"print","value":"2772-8293"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of indacaterol\/glycopyrronium\/mometasone for refractory asthmatic cough after switching from inhaled corticosteroid\/long-acting \u03b22-agonist therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2025.100567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100567"}}